At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01177 SINO BIOPHARM
Closed 05-03 16:09:00
2.870
-0.010
-0.35%
High2.980Low2.840Vol30.39M
Open2.980D1 Closing2.880Amplitude4.86%
Mkt Cap53.96BTradable Cap53.96BTotal Shares18.80B
T/O87.45MT/O Rate0.16%Tradable Shares18.80B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Sino Biopharmaceutical Full Year 2023 Earnings: Misses Expectations
Simply Wall St.  ·  05-02 06:33
Sino Biopharmaceutical Full Year 2023 Earnings: Misses Expectations
Mainland China stocks close lower ahead of long holiday, Hong Kong books best month since Jan 2023
Reuters  ·  04-30
Mainland China stocks close lower ahead of long holiday, Hong Kong books best month since Jan 2023
Executive Chairwoman of the Board of Sino Biopharmaceutical Y. Y. Tse Buys 167% More Shares
Simply Wall St.  ·  04-23
Executive Chairwoman of the Board of Sino Biopharmaceutical Y. Y. Tse Buys 167% More Shares
Hong Kong shares jump on policy support; China slips
Reuters  ·  04-22
Hong Kong shares jump on policy support; China slips
Greater China Stocks Close Mixed Monday; Hong Kong Leads Gainers
Dow Jones  ·  04-22
Greater China Stocks Close Mixed Monday; Hong Kong Leads Gainers
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings
Simply Wall St.  ·  04-21
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings
BRIEF-Sino Biopharmaceutical Posts FY Profit Attributable RMB2.33 Billion
Reuters  ·  03-28
BRIEF-Sino Biopharmaceutical Posts FY Profit Attributable RMB2.33 Billion
BRIEF-Sino Biopharmaceutical Says Approval For Marketing Of Iopromide Injection
Reuters  ·  03-25
BRIEF-Sino Biopharmaceutical Says Approval For Marketing Of Iopromide Injection
Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price
Simply Wall St.  ·  03-20
Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price
Sino Biopharmaceutical (HKG:1177) shareholders have endured a 60% loss from investing in the stock three years ago
Simply Wall St.  ·  03-02
Sino Biopharmaceutical (HKG:1177) shareholders have endured a 60% loss from investing in the stock three years ago
Individual investors who hold 37% of Sino Biopharmaceutical Limited (HKG:1177) gained 4.7%, insiders profited as well
Simply Wall St.  ·  02-13
Individual investors who hold 37% of Sino Biopharmaceutical Limited (HKG:1177) gained 4.7%, insiders profited as well
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Reuters  ·  02-07
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
BRIEF-Sino Biopharmaceutical Says Disposal Of Equity Interest In Cp Qingdao
Reuters  ·  02-06
BRIEF-Sino Biopharmaceutical Says Disposal Of Equity Interest In Cp Qingdao
BRIEF-Sino Biopharmaceutical Says Application For Market Launch Of "Obeticholic Acid Tablets" Accepted By NMPA
Reuters  ·  02-01
BRIEF-Sino Biopharmaceutical Says Application For Market Launch Of "Obeticholic Acid Tablets" Accepted By NMPA
Sino Biopharmaceutical Limited's (HKG:1177) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Simply Wall St.  ·  01-26
Sino Biopharmaceutical Limited's (HKG:1177) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
BRIEF-Sino Biopharmaceutical Says Purchased Aggregate Of 78.4 Million Shares Under Share Purchase Plan
Reuters  ·  01-24
BRIEF-Sino Biopharmaceutical Says Purchased Aggregate Of 78.4 Million Shares Under Share Purchase Plan
Japanese Index Hits New 33-Year High
Dow Jones  ·  01-09
Japanese Index Hits New 33-Year High
Sino Biopharmaceutical Insiders Placed Bullish Bets Worth CN¥162.5m
Simply Wall St.  ·  01-08
Sino Biopharmaceutical Insiders Placed Bullish Bets Worth CN¥162.5m
BRIEF-Sino Biopharmaceutical Says TRD205 Tablet Approved By NMPA Of China
Reuters  ·  2023-12-27
BRIEF-Sino Biopharmaceutical Says TRD205 Tablet Approved By NMPA Of China
Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon
Simply Wall St.  ·  2023-12-18
Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon

Introduction

Company Name.
SINO BIOPHARM
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is engaged in long term investments. The Others segment is engaged in the provision of research and development activities and services to third parties, as well as related healthcare and hospital business. The Company is also involved in the property holding, the sales of health food, the manufacture and optometry of optical glasses, as well as the retail and wholesale of optical and auditory products through its subsidiaries.
Issue price:
--